ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

South Korea flag South Korea · Delayed Price · Currency is KRW
901.00
+12.00 (1.35%)
At close: Jan 23, 2026
-10.70%
Market Cap27.91B
Revenue (ttm)60.50B
Net Income (ttm)-7.66B
Shares Out30.98M
EPS (ttm)-246.82
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume50,052
Average Volume65,522
Open896.00
Previous Close889.00
Day's Range880.00 - 909.00
52-Week Range873.00 - 1,420.00
Beta0.59
RSI28.48
Earnings DateMar 13, 2026

About KOSDAQ:034940

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i... [Read more]

Industry Pharmaceutical Preparations
Founded 1964
Employees 269
Stock Exchange KOSDAQ
Ticker Symbol 034940
Full Company Profile

Financial Performance

In 2024, KOSDAQ:034940's revenue was 62.69 billion, a decrease of -0.44% compared to the previous year's 62.97 billion. Losses were -9.60 billion, -8.65% less than in 2023.

Financial Statements